CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?
Abstract Chimeric antigen receptor (CAR) T-cell therapy wella color touch 77 45 targeting B cells has shown promising results, including drug-free remission, in adult-onset autoimmune diseases.Extending this therapeutic approach to the pediatric population, particularly for juvenile autoimmune diseases, presents an exciting opportunity.However, cha